Register for Webinar

PetDx Webinar in the IDEXX Learning Center

Show me the data! A look at real-world clinical performance and outcomes of liquid biopsy testing for cancer detection in 1,500 dogs

Blood-based liquid biopsy using next-generation sequencing became clinically available in May 2021. Since that time, the test has been ordered for thousands of patients, as a screening tool for dogs at higher risk of cancer, and as an aid in diagnosis for dogs for which there is a clinical suspicion of cancer. This session will by Dr. Andi Flory, chief medical officer at PetDx. The presentation will review data from a cohort of 1,500 consecutive liquid biopsy tests received for commercial testing, and will include a discussion of ordering patterns, positivity rates, and patient outcome data, along with how this data can be used to discuss liquid biopsy testing with clients. A series of interesting case studies will be presented, exploring the use of this testing in a variety of clinical settings.

This program has been approved for 1 hour of continuing education credit in jurisdictions that recognize RACE approval.

Speaker

Andi Flory

DVM, DACVIM (Oncology)
PetDx Chief Medical Officer 

Register for Webinar